SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 71
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 68 69 70 71
|
presentations:
1 to
50 of
3529
|
OVERVIEW: SCOTT M. HAMMER WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES (ABSTRACT
1)
Nicolas Chomont
Université de Montréal, Montréal, Canada
Serena S. Spudich
Yale University, New Haven, CT, United States
ADVANCES IN MOLECULAR VIROLOGY OF HIV AND SARS-CoV-2
Stuart J.D. Neil
King's College London, London, United Kingdom
ADVANCES IN HIV AND SARS-CoV-2 IMMUNOLOGY
Guido Silvestri
Emory University, Atlanta, GA, United States
ADVANCING RESEARCH: THE POWER OF COMMUNITY ENGAGEMENT
Dawn Averitt
The Well Project, Women’s Research Initiative on HIV/AIDS, South Strafford, VT, United States
ADVANCES IN HIV TREATMENT STRATEGIES
Monica Gandhi
University of California San Francisco, San Francisco, CA, United States
ADVANCES IN BIOMEDICAL PREVENTION OF HIV
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
ADVANCES IN HIV CURE
John W. Mellors
University of Pittsburgh, Pittsburgh, PA, United States
A CALL TO ACTION FOR NEW INVESTIGATORS: OPPORTUNITIES IN RESEARCH AND PUBLIC HEALTH
Rochelle Walensky
Centers for Disease Control and Prevention, Atlanta, GA, United States
SESSION OVERVIEW: CASE-BASED LIVER WORKSHOP
Christoph Boesecke
Bonn University Hospital, Bonn, Germany
Debika Bhattacharya
University of California Los Angeles, Los Angeles, CA, United States
FULMINANT HEPATITIS IN CHILDREN (ABSTRACT
6)
Luz Helena Gutierrez Sanchez
University of Alabama at Birmingham, Birmingham, AL, United States
HBV PREVENTION: NEWER VACCINES AND THE BOUNDARIES OF HBV PROTECTION (ABSTRACT
7)
H. Nina Kim
University of Washington, Seattle, WA, United States
HEPATITIS DELTA INFECTION AMONG PERSONS LIVING WITH HIV (ABSTRACT
8)
Charles Béguelin
University of Bern, Bern, Switzerland
ADAPTIVE PLATFORM TRIALS: EXPERIENCE FROM THE COVID-19 PANDEMIC (ABSTRACT
9)
Michael D. Hughes
Harvard T.H. Chan School of Public Health, Boston, MA, United States
UNPACKING MODELING STUDIES (ABSTRACT
10)
Viviane D. Lima
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
SOCIAL AND BEHAVIORAL SCIENCE: THE MISSING INGREDIENT TO SUCCESSFUL CLINICAL TRIALS (ABSTRACT
11)
Heidi van Rooyen
Human Sciences Research Council, Cape Town, South Africa
SESSION OVERVIEW: FRONTIERS IN LABORATORY TECHNOLOGIES
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, United States
SINGLE-CELL ANALYSIS OF THE RNA, PROTEIN, AND GLYCAN FEATURES OF HIV-INFECTED CELLS (ABSTRACT
2)
Nadia R. Roan
Gladstone Institutes, San Francisco, CA, United States
SINGLE-CELL MULTIOMIC ANALYSES OF THE HIV RESERVOIR (ABSTRACT
3)
Michael R. Betts
University of Pennsylvania, Philadelphia, PA, United States
SINGLE-CELL MULTIOMICS AND EXPANSION DYNAMICS OF HIV RESERVOIR OVER SPACE AND TIME (ABSTRACT
4)
Ya-Chi Ho
Yale University, New Haven, CT, United States
NOVEL APPROACHES TO CHARACTERIZING IMMUNE RECOGNITION (ABSTRACT
5)
Michael Birnbaum
Massachusetts Institute of Technology, Cambridge, MA, United States
WELCOME FROM THE CROI 2023 CHAIR
James A. Hoxie
University of Pennsylvania, Philadelphia, PA, United States
MODELING THE DYNAMICS OF HIV INFECTION: ESTABLISHING PARADIGMS FOR TREATMENT AND CURE (ABSTRACT
12)
Alan S. Perelson
Los Alamos National Laboratory, Los Alamos, NM, United States
INTRODUCTION OF THE N'GALY-MANN LECTURE
Diane V. Havlir
University of California San Francisco, San Francisco, CA, United States
HIV AND GLOBAL HEALTH IN A PANDEMIC ERA (ABSTRACT
13)
Kevin M. De Cock
Centers for Disease Control and Prevention (former), Nairobi, Kenya
INTRODUCTION OF THE MARTIN DELANEY PRESENTATION
Dawn Averitt
The Well Project, Women’s Research Initiative on HIV/AIDS, South Strafford, VT, United States
COMMUNITY AND ADVOCATES ARE EQUAL PARTNERS IN RESEARCH AND DEVELOPMENT (ABSTRACT
14)
Yvette A. Raphael
Advocacy for Prevention of HIV and AIDS, Midrand, South Africa
RECOGNITION OF THE 30TH CROI: PRESENTATION OF VIDEO RETROSPECTIVE
Landon Myer
University of Cape Town, Cape Town, South Africa
INTRODUCTION OF DR FAUCI
Robert T. Schooley
University of California San Diego, San Diego, CA, United States
CROI: A 30-YEAR CHRONICLE OF HIV/AIDS RESEARCH PROGRESS
Anthony S. Fauci
National Institutes of Health (former), Washington, DC, United States
CLOSING REMARKS
James A. Hoxie
University of Pennsylvania, Philadelphia, PA, United States
CROI PROGRAM COMMITTEE CHAIR WELCOME TO MONDAY
James A. Hoxie
University of Pennsylvania, Philadelphia, PA, United States
INTRODUCTION OF JOHN NKENGASONG
Wafaa M. El-Sadr
Columbia University, New York, NY, United States
20 YEARS OF PEPFAR: LOOKING BACK, STRIDING FORWARD (ABSTRACT
15)
John Nkengasong
US Department of State, Washington, DC, United States
INTRODUCTION OF ANNA LOK
David L. Thomas
The Johns Hopkins University, Baltimore, MD, United States
THE PATH TO HEPATITIS B CURE (ABSTRACT
16)
Anna S. Lok
University of Michigan, Ann Arbor, MI, United States
INTRODUCTIONS (Part 1)
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Renee Heffron
University of Alabama at Birmingham, Birmingham, AL, United States
MUCOSAL PHARMACOLOGY OF DOXYCYCLINE FOR BACTERIAL STI PREVENTION IN MEN AND WOMEN (ABSTRACT
118)
Richard Haaland
Centers for Disease Control and Prevention, Atlanta, GA, United States
ANRS 174 DOXYVAC: AN OPEN-LABEL RANDOMIZED TRIAL TO PREVENT STIs IN MSM ON PrEP (ABSTRACT
119)
Jean-Michel Molina
University of Paris Cité, Paris, France
DOXYPEP & ANTIMICROBIAL RESISTANCE IN N. GONORRHOEAE, COMMENSAL NEISSERIA & S. AUREUS (ABSTRACT
120)
Anne F. Luetkemeyer
University of California San Francisco, San Francisco, CA, United States
DOXYCYCLINE POSTEXPOSURE PROPHYLAXIS FOR PREVENTION OF STIs AMONG CISGENDER WOMEN (ABSTRACT
121)
Jenell Stewart
University of Minnesota, Minneapolis, MN, United States
QUESTIONS AND ANSWERS (Part 1)
Renee Heffron
University of Alabama at Birmingham, Birmingham, AL, United States
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
INTRODUCTIONS (Part 2)
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Renee Heffron
University of Alabama at Birmingham, Birmingham, AL, United States
POTENTIAL IMPACT AND EFFICIENCY OF DOXY-PEP AMONG PEOPLE WITH OR AT RISK OF HIV (ABSTRACT
122)
Michael W. Traeger
Harvard Medical School, Boston, MA, United States
CLUSTER RANDOMISED TRIAL OF RISK-DIFFERENTIATED CARE FOR FEMALE SEX WORKERS: AMETHIST (ABSTRACT
123)
Frances M. Cowan
Liverpool School of Tropical Medicine, Harare, Zimbabwe
RANDOMIZED TRIAL OF COMMUNITY HEALTH WORKER DELIVERED DYNAMIC CHOICE HIV PREVENTION (ABSTRACT
124)
Elijah Kakande
Infectious Diseases Research Collaboration, Kampala, Uganda
CLUSTER RANDOMIZED TRIAL OF INTEGRATED HIV AND SEXUAL & REPRODUCTIVE HEALTH SERVICES (ABSTRACT
125)
Rashida Ferrand
London School of Hygiene & Tropical Medicine, London, United Kingdom
QUESTIONS AND ANSWERS (Part 2)
Renee Heffron
University of Alabama at Birmingham, Birmingham, AL, United States
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
RECENT HIV INFECTION SURVEILLANCE IN BREASTFEEDING WOMEN IN MALAWI: JUL 2019-JUL 2022 (ABSTRACT
126)
Davie D. Chalira
International Training and Education Center for Health, Lilongwe, Malawi
DELIVER: A SAFETY STUDY OF A DAPIVIRINE VAGINAL RING AND ORAL PrEP DURING PREGNANCY (ABSTRACT
127)
Katherine E. Bunge
University of Pittsburgh, Pittsburgh, PA, United States
RANDOMIZED TRIAL OF DYNAMIC CHOICE HIV PREVENTION IN ANTE/POSTNATAL CARE CLINICS (ABSTRACT
128)
Moses Kamya
Makerere University, Kampala, Uganda
|
<< first | < prev
page:
of 71
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 68 69 70 71
|
presentations:
1 to
50 of
3529
|
